Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erratum to "lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2". | Open Med (Wars) | 2022 | 36660018 | PubTator, text mining | PubMed |
| FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers. | Noncoding RNA | 2022 | 36649030 | PubTator, text mining | PubMed |
| Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. | Front Cell Dev Biol | 2022 | 36619866 | PubTator, text mining | PubMed |
| Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. | Dis Markers | 2022 | 36618967 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson's Disease. | Oxid Med Cell Longev | 2022 | 36593912 | PubTator, text mining | PubMed |
| Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells. | Asian Pac J Cancer Prev | 2022 | 36579996 | PubTator, text mining | PubMed |
| Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer. | Front Oncol | 2022 | 36578931 | PubTator, text mining | PubMed |
| TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study. | Front Genet | 2022 | 36568387 | PubTator, text mining | PubMed |
| High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma. | Biomed Res Int | 2022 | 36567912 | PubTator, text mining | PubMed |
| The role of erythrocytes and erythroid progenitor cells in tumors. | Open Life Sci | 2022 | 36567722 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| Expression Profiles of CDKN2A, MDM2, E2F2 and LTF Genes in Oral Squamous Cell Carcinoma. | Biomedicines | 2022 | 36551770 | PubTator, text mining | PubMed |
| κ- and λ-Carrageenans from Marine Alga Chondrus armatus Exhibit Anticancer In Vitro Activity in Human Gastrointestinal Cancers Models. | Mar Drugs | 2022 | 36547888 | PubTator, text mining | PubMed |
| EKLF/Klf1 regulates erythroid transcription by its pioneering activity and selective control of RNA Pol II pause-release. | Cell Rep | 2022 | 36543143 | PubTator, text mining | PubMed |
| NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family. | Clin Epigenetics | 2022 | 36539894 | PubTator, text mining | PubMed |
| Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity. | Mil Med Res | 2022 | 36529792 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis for MEF2 family genes in gastric cancer. | Transl Cancer Res | 2022 | 36523311 | PubTator, text mining | PubMed |
| Bone marrow mesenchymal stem cell-derived exosomal LINC00847 inhibits the proliferation, migration, and invasion of Ewing sarcoma. | J Clin Transl Res | 2022 | 36518202 | PubTator, text mining | PubMed |
| Targeting macrophages: a novel treatment strategy in solid tumors. | J Transl Med | 2022 | 36510315 | PubTator, text mining | PubMed |
| Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor. | Front Med (Lausanne) | 2022 | 36507526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=20